FIRST AMENDMENT TO LETTER AGREEMENTLetter Agreement • March 16th, 2021 • Kindred Biosciences, Inc. • Pharmaceutical preparations
This 1st Amendment to the Letter Agreement ( “Amendment”) is made as of March 8, 2021 (the “Effective Date”) by and between Elanco US, Inc. (“Elanco”) and Kindred Biosciences, Inc. (“KindredBio”). Elanco and KindredBio are each referred to herein as a “Party” and collectively as the “Parties”.
FOURTH ADDENDUM TO ORITZ BUILDING OFFICE LEASEOffice Lease Addendum • March 16th, 2021 • Kindred Biosciences, Inc. • Pharmaceutical preparations
All terms and conditions remain unchanged from Original Office Lease signed between Oritz Properties, Inc, a California corporation (“Landlord”) and Kindred Biosciences, Inc. (“Tenant”), except for the following:
ContractLicense Agreement • March 16th, 2021 • Kindred Biosciences, Inc. • Pharmaceutical preparations • Delaware
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. SUCH EXCLUDED INFORMATION HAS BEEN MARKED WITH “[*]”.
